One Agency Is Melting Down Over Trump's Win
They Fell for It: Why a Conservative Podcast Is Making Fun of Axios...
CNN Reporter's Take on Trump Supporters and How They See the Network Is...
The One Line CNN's Scott Jennings Used to Shut Down a Testy Journalist
There Appears to Be a Planned and Organized Pogrom Happening in Amsterdam
'From the Jailhouse to the Texas House': Candidate Who Defied COVID Restrictions Wins...
KJP Pressed to Explain Biden's Past Rhetoric About Trump With His Post-Election Messaging
How Trump's Win Is Already Having an Impact on Illegal Immigration
Why Trump Won
Good News: Americans Are No Longer Listening to Mass Media
France's Largest Newspaper Had This to Say About Trump's Win
Donald Trump Just Won a Mandate. And It's Huge.
Restoration in Progress
The Aftermath
An Open Letter to the Left's Unremarkable, Bitter, Woke, Visionless, Out-of-Touch Leadersh...
Tipsheet

Trump Touts Proposal to Lower Drug Prices

"We are getting tough on the drug makers that exploit our patent laws to choke out competition," President Trump said outside the White House Friday outlining his plan to lower prescription drug prices. 

Advertisement

"Our patent system will reward innovation," he said. "But it will not be used as a shield to protect unfair monopolies."

The drug lobby, he continued, is making a fortune. That's why he's pushing for reform.

"This is the most comprehensive action plan" in history, HHS Secretary Alex Azar said after Trump's remarks.

The president's blueprint is "a sophisticated approach," he added. 

Everybody at HHS "is rolling up their sleeves" and getting to work on the 50 action items included in the proposal.

A couple of those items include expanding private sector negotiations for Medicare and getting drug companies to disclose their prices in their ads. That way, "consumers would have more balanced information."

Advertisement

At the White House press briefing, Azar outlined the administration's four-part program. One, increase competition. Two, increase better negotiations on Medicare. Three, foster incentives to lower list prices. Four, lower out-of-pocket costs. 

Zeke Emanuel, a former healthy policy adviser for President Obama, responded immediately on CNN. He said Trump's proposal will do little to lower drug prices because "you have to confront the drug industry." 

He won't do it "because his Republican colleagues don't like that idea."

You can read Trump's complete proposal here. It is one that will "put American patients first."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement